Targeting autophagy during cancer therapy to improve clinical outcomes
- 1 July 2011
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 131 (1) , 130-141
- https://doi.org/10.1016/j.pharmthera.2011.03.009
Abstract
No abstract availableKeywords
Funding Information
- St. Baldrick's Foundation Fellowship
- The Morgan Adams Foundation
- NIH (CA150925, CA111421)
This publication has 187 references indexed in Scilit:
- Autophagy and TumorigenesisSeminars in Immunopathology, 2010
- Autophagy: assays and artifactsThe Journal of Pathology, 2010
- Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology RevisitedThe International Journal of Cell Cloning, 2010
- Methods in Mammalian Autophagy ResearchCell, 2010
- Autophagy Suppresses Tumorigenesis through Elimination of p62Published by Elsevier ,2009
- Down‐regulation of Bax‐interacting factor‐1 in colorectal adenocarcinomaCancer, 2008
- A Molecule Targeting VHL-Deficient Renal Cell Carcinoma that Induces AutophagyCancer Cell, 2008
- RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acidThe Prostate, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesisPublished by Elsevier ,2006